Second, the relatively small number of FTD participants who underwent tau PET imaging, particularly in the A + T − and A + T + stages, limited the analysis of plasma biomarkers and clinical trajectories; therefore, these strata are reported descriptively with exact n indicated and interpreted as hypothesis-generating, underscoring the need for confirmation in larger, multicenter cohorts. This evidence concerns the gene MAPT and frontotemporal dementia.